Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

Italy

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Roma

Ospedale Cardinale G. Panico, Tricase